Company Filing History:
Years Active: 2018-2023
Title: Kerstin Kapp: Innovator in Viral Infection Treatment
Introduction
Kerstin Kapp is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medical science, particularly in the treatment of viral infections. With a total of 6 patents to her name, her work has the potential to impact the lives of many patients suffering from retroviral infections.
Latest Patents
Kapp's latest patents include innovative methods for treating retroviral infections. One notable invention involves a non-coding sequence of deoxyribonucleic acids that comprises at least one sequence motif NNCGNN. This invention is particularly relevant for the treatment of viral infections, as it is used in combination with antiretroviral therapy and/or histone de-acetylase inhibitors. Another significant patent focuses on a combination of T-cell regulators and non-coding immunomodulating DNA for the treatment of various diseases.
Career Highlights
Throughout her career, Kapp has worked with notable companies such as Mologen AG and Gilead Sciences, Inc. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the field of viral infection treatment.
Collaborations
Kapp has collaborated with esteemed colleagues, including Matthias Schroff and Manuel Schmidt. These partnerships have further enhanced her research and development efforts in the medical field.
Conclusion
Kerstin Kapp is a trailblazer in the realm of viral infection treatment, with a strong portfolio of patents that showcase her innovative spirit. Her contributions to medical science are invaluable and continue to pave the way for future advancements in the field.